Factor V Leiden in Ischaemic Heart Disease
Screening of Factor V Leiden Mutation in Egyptian Patients with Ischaemic Heart Disease
978-3-659-81201-9
3659812013
128
2015-12-07
61.90 €
eng
https://images.our-assets.com/cover/230x230/9783659812019.jpg
https://images.our-assets.com/fullcover/230x230/9783659812019.jpg
https://images.our-assets.com/cover/2000x/9783659812019.jpg
https://images.our-assets.com/fullcover/2000x/9783659812019.jpg
Thrombosis is a major mechanism of cardiovascular disease and is a leading cause of death. Thrombosis generally occurs in the setting of imbalance in haemostatic regulation favoring blood clot formation. Activated protein C (APC) is a naturally circulating anticoagulant protein in plasma, which exerts its effects mainly by breaking down activated factor V in the coagulation cascade. A single point mutation in the coagulation factor V gene (FV R506Q) renders factor V resistant to inactivation by APC. The frequency of this mutation is known to be significantly increased in patients with thrombophilia. The influence of factor V Leiden mutation on the risk of arterial thrombosis has been the topic of this investigation. Numerous studies showed a strong correlation between APC-resistance, factor V Leiden mutation and venous thrombosis, whereas the relationship between these defects and the arterial thrombosis are controversial.
https://morebooks.de/books/fr/published_by/lap-lambert-academic-publishing/47/products
Médecine
https://morebooks.de/store/fr/book/factor-v-leiden-in-ischaemic-heart-disease/isbn/978-3-659-81201-9